MCR 313 (Lamivudine 150 mg)
Pill with imprint MCR 313 is White, Four-sided and has been identified as Lamivudine 150 mg. It is supplied by Appco Pharma LLC.
Lamivudine is used in the treatment of hepatitis b; hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Lamivudine 150 mg is not a controlled substance under the Controlled Substance Act (CSA).
Images for MCR 313
Lamivudine
- Imprint:
- MCR 313
- Strength:
- 150 mg
- Color:
- White
- Shape:
- Four-sided
- Availability:
- Prescription only
- Drug Class:
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Appco Pharma LLC
- National Drug Code (NDC):
- 55801-0313
More about lamivudine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 3 Reviews – Add your own review/rating
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
Consumer resources
Other brands: Epivir, Epivir-HBV
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
